Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 284.00
-4.00 (-1.39%)
Mar 10, 2026, 2:34 PM JST
Perseus Proteomics Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 1,236 | 1,667 | 1,541 | 2,444 | 3,214 | 1,069 | Upgrade
|
| Cash & Short-Term Investments | 1,236 | 1,667 | 1,541 | 2,444 | 3,214 | 1,069 | Upgrade
|
| Cash Growth | -34.23% | 8.18% | -36.95% | -23.96% | 200.65% | 121.78% | Upgrade
|
| Accounts Receivable | 21.91 | 22 | 13 | 9 | 10 | 8 | Upgrade
|
| Other Receivables | 26.46 | 50 | 70 | 41 | 35 | 21 | Upgrade
|
| Receivables | 48.36 | 72 | 83 | 50 | 45 | 29 | Upgrade
|
| Inventory | 5.31 | 5 | 4 | 3 | 3 | 1 | Upgrade
|
| Prepaid Expenses | 11.07 | 11 | 5 | 7 | 4 | 4 | Upgrade
|
| Other Current Assets | 7.39 | 20 | 17 | 10 | 24 | 5 | Upgrade
|
| Total Current Assets | 1,308 | 1,775 | 1,650 | 2,514 | 3,290 | 1,108 | Upgrade
|
| Long-Term Investments | 14.68 | 42 | 42 | 51 | 9 | 9 | Upgrade
|
| Other Long-Term Assets | 0 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Total Assets | 1,323 | 1,818 | 1,693 | 2,566 | 3,300 | 1,118 | Upgrade
|
| Accounts Payable | 43.79 | - | 1 | 1 | - | 1 | Upgrade
|
| Accrued Expenses | 41.76 | 41 | 57 | 28 | 11 | 8 | Upgrade
|
| Current Income Taxes Payable | 1.45 | 79 | 66 | 66 | 134 | 24 | Upgrade
|
| Other Current Liabilities | 14.32 | 4 | 4 | 16 | 3 | 1 | Upgrade
|
| Total Current Liabilities | 101.31 | 124 | 128 | 111 | 148 | 34 | Upgrade
|
| Other Long-Term Liabilities | 336.57 | 262 | 167 | 59 | - | 1 | Upgrade
|
| Total Liabilities | 437.88 | 386 | 295 | 170 | 148 | 35 | Upgrade
|
| Common Stock | 500 | 2,437 | 1,971 | 1,939 | 1,939 | 604 | Upgrade
|
| Additional Paid-In Capital | 853.2 | 2,723 | 2,256 | 2,225 | 2,225 | 889 | Upgrade
|
| Retained Earnings | -547.78 | -3,808 | -2,903 | -1,799 | -1,012 | -413 | Upgrade
|
| Comprehensive Income & Other | 79.22 | 80 | 74 | 31 | - | 3 | Upgrade
|
| Shareholders' Equity | 884.63 | 1,432 | 1,398 | 2,396 | 3,152 | 1,083 | Upgrade
|
| Total Liabilities & Equity | 1,323 | 1,818 | 1,693 | 2,566 | 3,300 | 1,118 | Upgrade
|
| Net Cash (Debt) | 1,236 | 1,667 | 1,541 | 2,444 | 3,214 | 1,069 | Upgrade
|
| Net Cash Growth | -34.23% | 8.18% | -36.95% | -23.96% | 200.65% | 121.78% | Upgrade
|
| Net Cash Per Share | 83.80 | 116.83 | 130.72 | 207.83 | 292.27 | 152.72 | Upgrade
|
| Filing Date Shares Outstanding | 14.75 | 14.75 | 11.85 | 11.76 | 11.75 | 8.36 | Upgrade
|
| Total Common Shares Outstanding | 14.75 | 14.75 | 11.85 | 11.76 | 11.75 | 8.36 | Upgrade
|
| Working Capital | 1,207 | 1,651 | 1,522 | 2,403 | 3,142 | 1,074 | Upgrade
|
| Book Value Per Share | 59.98 | 97.09 | 118.00 | 203.75 | 268.36 | 129.53 | Upgrade
|
| Tangible Book Value | 884.63 | 1,432 | 1,398 | 2,396 | 3,152 | 1,083 | Upgrade
|
| Tangible Book Value Per Share | 59.98 | 97.09 | 118.00 | 203.75 | 268.36 | 129.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.